Endoscopic and histological characteristics in patients with eosinophilic esophagitis responsive and non-responsive to proton pump inhibitors
- PMID: 31361987
- PMCID: PMC9432158
- DOI: 10.1016/j.jped.2019.05.005
Endoscopic and histological characteristics in patients with eosinophilic esophagitis responsive and non-responsive to proton pump inhibitors
Abstract
Objective: To compare endoscopic and histologic features of pediatric patients with eosinophilic esophagitis (EoE) responding to proton pump inhibitor (PPI) to those not responding to PPI.
Methods: Endoscopic reports and photographs of patients with symptoms of esophageal dysfunction and ≥15 eosinophils per high-powered field (eos/hpf) in esophageal biopsies prior to PPI trial were reviewed. Patients were classified as responsive to PPI (PPIREoE) or non-responsive to PPI (PPINREoE) according to response totreatment (<15 eos/hpf) at second endoscopy after 8 weeks.
Results: Of the 231 patients (72.3% male), 64 (27.7%) were responsive to the proton pump inhibitors. Edema (77.3% vs. 62.5%, p=0.031) and vertical lines (69.5% vs. 51.6%, p=0.014) were more frequent in PPINREoE patients. An eosinophil count in the mid-esophagus ≥ 35 eos/HPF (25.1% vs. 12.5%) was more frequent in these patients (p=0.001). Those with eosinophil count < 15 eos/HPF in the mid-esophagus at the first endoscopy were more likely to respond to treatment with proton pump inhibitors compared to patients with 15-34 eos/HPF (p=0.004, OR: 3.26, 95% CI: 1.46-7.24) and to patients with ≥ 35 eos/HPF (p=0.006, OR: 3.20, 95% CI: 1.39-7.41).
Conclusion: Edema and vertical lines at the endoscopy and a higher eosinophil count in the mid-esophagus were more frequent in patients who were non-responsive to proton pump inhibitors. As there were no significant differences in the other findings between the groups, it cannot be affirmed that these characteristics are sufficient to differentiate between PPINREoE and PPIREoE patients.
Objetivo: Comparar características endoscópicas e histológicas entre pacientes com esofagite eosinofílica responsiva (EoERIBP) e não responsiva (EoENRIBP) ao tratamento com inibidores de bomba de prótons.
Métodos: Avaliados laudos e imagens endoscópicas de pacientes com sintomas de disfunção esofágica associados a contagem ≥15 eosinófilos por campo de grande aumento (eos/CGA) em biópsia do esôfago. Os pacientes foram classificados em responsivos (EoERIBP) ou não responsivos (EoENRIBP) aos inibidores de bomba de prótons conforme resposta ao tratamento na segunda endoscopia (<15 eos/CGA) após 8 semanas.
Resultados: Dos 231 pacientes (72,3% masculino), 64 (27,7%) foram responsivos aos inibidores de bomba de prótons. Edema (77,3% vs. 62,5%, p = 0,031) e linhas verticais (69,5% vs. 51,6%, p = 0,014) foram mais frequentes nos EoENRIBP. A contagem de eosinófilos em esôfago médio ≥35 eos/CGA (25,1% vs. 12,5%) foi mais frequente nesses pacientes (p = 0,001). Os que apresentaram contagem de eosinófilos <15 eos/CGA no esôfago médio à primeira endoscopia apresentaram maior chance de responder ao tratamento com inibidores de bomba de prótons em comparação aos pacientes com 15-34 eos/CGA (p = 0,004; OR: 3,26; IC95%: 1,46 - 7,24) e aos pacientes com ≥35 eos/CGA (p = 0,006; OR: 3,20; IC95%: 1,39 - 7,41).
Conclusão: Edema e linhas verticais à endoscopia e maior contagem de eosinófilos em esôfago médio foram mais frequentes nos pacientes não responsivos aos inibidores de bomba de prótons. Uma vez que não houve diferenças significativas nos outros achados entre os grupos, não se pode afirmar que essas características sejam suficientes para distinguir pacientes com EoENRIBP dos pacientes com EoERIBP.
Keywords: Endoscopia; Endoscopy; Eosinophilic esophagitis; Esofagite eosinofílica; Histologia; Histology; Inibidores de bomba de prótons; Proton pump inhibitors.
Copyright © 2019 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.
Figures
Similar articles
-
Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study.Am J Gastroenterol. 2013 Dec;108(12):1854-60. doi: 10.1038/ajg.2013.363. Epub 2013 Oct 22. Am J Gastroenterol. 2013. PMID: 24145677 Free PMC article.
-
Effect of proton pump inhibitor on esophageal eosinophilia.J Pediatr Gastroenterol Nutr. 2013 Feb;56(2):166-72. doi: 10.1097/MPG.0b013e3182716b7a. J Pediatr Gastroenterol Nutr. 2013. PMID: 23325438 Free PMC article.
-
Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.Clin Gastroenterol Hepatol. 2014 Nov;12(11):1815-23.e2. doi: 10.1016/j.cgh.2014.02.037. Epub 2014 Mar 19. Clin Gastroenterol Hepatol. 2014. PMID: 24657840
-
Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE).Dig Liver Dis. 2017 Mar;49(3):254-260. doi: 10.1016/j.dld.2016.11.012. Epub 2016 Dec 2. Dig Liver Dis. 2017. PMID: 27979389 Review.
-
Eosinophilic esophagitis-Where are we today?J Pediatr (Rio J). 2019 May-Jun;95(3):275-281. doi: 10.1016/j.jped.2018.06.012. Epub 2018 Aug 1. J Pediatr (Rio J). 2019. PMID: 30075121 Review.
Cited by
-
Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions.J Asthma Allergy. 2022 Feb 26;15:281-302. doi: 10.2147/JAA.S274524. eCollection 2022. J Asthma Allergy. 2022. PMID: 35250281 Free PMC article. Review.
-
Oesophageal wall thickness assessment at endoscopic ultrasound in children and adolescents with eosinophilic oesophagitis: a case-control study.J Ultrasound. 2023 Dec;26(4):785-791. doi: 10.1007/s40477-022-00742-8. Epub 2022 Dec 27. J Ultrasound. 2023. PMID: 36574193 Free PMC article.
-
British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.Gut. 2022 Aug;71(8):1459-1487. doi: 10.1136/gutjnl-2022-327326. Epub 2022 May 23. Gut. 2022. PMID: 35606089 Free PMC article.
-
Review of Non-Eosinophilic Esophagitis-Eosinophilic Gastrointestinal Disease (Non-EoE-EGID) and a Case Series of Twenty-Eight Affected Patients.Biomolecules. 2023 Sep 20;13(9):1417. doi: 10.3390/biom13091417. Biomolecules. 2023. PMID: 37759817 Free PMC article. Review.
-
Proton-Pump Inhibitors in Eosinophilic Esophagitis: A Review Focused on the Role of Pharmacogenetics.Pharmaceutics. 2024 Apr 2;16(4):487. doi: 10.3390/pharmaceutics16040487. Pharmaceutics. 2024. PMID: 38675148 Free PMC article. Review.
References
-
- Liacouras C.A., Spergel J.M., Ruchelli E., Verma R., Mascarenhas M., Semeao E., et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198–1206. - PubMed
-
- Blanchard C., Wang N., Rothenberg M.E. Eosinophilic esophagitis: pathogenesis, genetics, and therapy. J Allergy Clin Immunol. 2006;118:1054–1059. - PubMed
-
- Furuta G.T., Liacouras C.A., Collins M.H., Gupta S.K., Justinich C., Putnam P.E., et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363. - PubMed
-
- Ferreira C.T., Vieira M.C., Furuta G.T., Barros F.C., Chehade M. Eosinophilic esophagitis — where are we today? J Pediatr (Rio J) 2019;95:275–281. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials